Screener
Beta Bionics BBNX EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Beta Bionics’s reported figures.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
FAQ
- What is Beta Bionics's EBITDA?
- Beta Bionics (BBNX) reported EBITDA of -$24.87M in Q2 2026.
- How has Beta Bionics's EBITDA changed year-over-year?
- Beta Bionics's EBITDA decreased by 27.4% year-over-year, from -$19.53M to -$24.87M.
- What is the long-term trend for Beta Bionics's EBITDA?
- Over 2 years (2023 to 2025), Beta Bionics's EBITDA has grown at a 42.3% compound annual growth rate (CAGR), from -$34.62M to -$70.11M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Beta Bionics's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude